Merck & Co. Inc (MRCK34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 22 Oct 2026
Key indicators
| Last close | BRL 93.16 |
|---|---|
| 52-week range | 55.23 – 101.38 |
| Return, 1 month / 3 months | −3.6% / +15.6% |
| Return, 1 year / 3 years | +59.6% / +52.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 51 |
| Volatility (1 year) | 35.8% |
| Worst drawdown (1 year) | -14.8% |
| Average daily value traded | 0.51M BRL |
| Dividend yield | 6.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Merck & Co. is a pharmaceutical company based in the United States that discovers, develops and manufactures prescription medicines, vaccines and animal health products. Its human health business serves patients and healthcare providers through treatments for cancer, diabetes, infectious diseases and other conditions, while its animal health arm supplies veterinary medicines and vaccines to livestock and companion animal owners. The company sells its products to wholesalers, hospitals, pharmacies and governments in markets around the world.
Merck & Co. Inc is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code MRCK34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Merck & Co. Inc (MRCK34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 93.16 on 22 October 2026.
Its price-based Market X-Ray is 77 out of 100 (a strong price profile), ranking 48 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 59.6% and over the last three months it rose 15.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 83 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 15.8% | ||
| From 52-week high | -8.1% | ||
| Momentum | 87 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 15.6% | ||
| 6-month return | 32.9% | ||
| 12-month return, skipping the last month | 65.5% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.8% | ||
| Liquidity | 71 · Strong | Trades actively. | |
| Average daily value traded | 0.51M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 63 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.0% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.5% |
|---|---|
| 1 month | −3.6% |
| 3 months | +15.6% |
| 6 months | +32.9% |
| 1 year | +59.6% |
| 3 years | +52.8% |
| 5 years | +82.0% |
Signals
| 50-day / 200-day average | 94.05 / 80.42 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.55 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Jun 2026 | USD 0.3689 |
| 12 Mar 2026 | USD 0.3658 |
| 11 Dec 2025 | USD 0.3860 |
| 11 Sep 2025 | USD 0.3659 |
| 12 Jun 2025 | USD 0.3741 |
| 13 Mar 2025 | USD 0.4066 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.